At least five biotechs and pharmas are slated to report earnings this week. 4Q12 EPS for Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) is expected to increase 2X on a 32% jump in revenues to $70 million. Spectrum acquired fellow cancer company Allos Therapeutics Inc.